Institutional
Artia Global Partners LP
CIK 0001937964
$499.4M
Reported AUM
49
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · Artia Global Partners LP · Q1 2026
AI · grounded in 13F
Artia Global Partners LP exited its position in ProShares TR II UGL, reducing its exposure by $30.1M. The fund also closed its position in uniQure NV QURE for $24.5M. On the buy side, the fund established a new position in AstraZeneca PLC AZN worth $18.8M and added Moderna Inc MRNA with a $10.2M investment.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | INSM | INSMED INC | $92.67 | -1.65% | 27.98% | 283.01% | $148.5M | 29.74% | −193,800 | −17.6% |
| 2 | ABVX | ABIVAX SA | $101.53 | -3.24% | 1139.68% | 900.30% | $66.9M | 13.39% | −9,900 | −1.6% |
| 3 | LLY | ELI LILLY & CO | $1131.42 | 0.55% | 48.00% | 387.10% | $35.2M | 7.04% | −12,280 | −24.3% |
| 4 | TRVI | TREVI THERAPEUTICS INC | $13.33 | -4.31% | 88.81% | 601.58% | $24.0M | 4.81% | — | HELD |
| 5 | ARGX | ARGENX SE | $892.67 | 0.15% | 52.12% | 192.78% | $21.7M | 4.35% | −34,960 | −54.0% |
| 6 | AZN | ASTRAZENECA PLC | $185.95 | 2.28% | 29.80% | 80.46% | $18.8M | 3.77% | +95,376 | NEW |
| 7 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $31.17 | -1.09% | 56.50% | 225.62% | $16.1M | 3.23% | — | HELD |
| 8 | DNTH | DIANTHUS THERAPEUTICS INC | $80.51 | -4.30% | 327.11% | -29.33% | $13.7M | 2.74% | −42,100 | −20.5% |
| 9 | RVMD | REVOLUTION MEDICINES INC | $149.23 | -4.15% | 263.18% | 421.05% | $12.2M | 2.43% | +20,800 | +20.0% |
| 10 | IONS | IONIS PHARMACEUTICALS INC | $73.61 | -1.16% | 111.05% | 100.54% | $10.8M | 2.17% | — | HELD |
| 11 | MRNA | MODERNA INC | $47.48 | 0.08% | 72.76% | -86.58% | $10.2M | 2.03% | +200,000 | NEW |
| 12 | EYPT | EYEPOINT INC | $11.64 | -1.19% | 31.77% | 43.31% | $9.9M | 1.98% | — | HELD |
| 13 | DGX | QUEST DIAGNOSTICS INC | $199.33 | -0.48% | 16.96% | 55.76% | $8.0M | 1.60% | — | HELD |
| 14 | ALMS | ALUMIS INC | $19.06 | -6.52% | 430.92% | 54.96% | $7.2M | 1.43% | +325,046 | NEW |
| 15 | VKTX | VIKING THERAPEUTICS INC | $28.69 | 0.86% | 2.23% | 362.60% | $5.9M | 1.18% | −538,634 | −74.9% |
| 16 | MRK | MERCK & CO INC | $120.79 | 0.44% | 58.51% | 82.35% | $5.6M | 1.12% | +46,700 | NEW |
| 17 | 430 | TERNS PHARMACEUTICALS INC | — | — | — | — | $5.5M | 1.11% | +104,800 | NEW |
| 18 | JNJ | JOHNSON & JOHNSON | $232.77 | 2.02% | 53.90% | 55.59% | $5.5M | 1.11% | +22,600 | NEW |
| 19 | SION | SIONNA THERAPEUTICS INC | $33.48 | -5.34% | 105.40% | 238.15% | $4.8M | 0.96% | — | HELD |
| 20 | SRRK | SCHOLAR ROCK HLDG CORP | $45.16 | 1.94% | 29.42% | 41.76% | $4.7M | 0.95% | — | HELD |
| 21 | RAPP | RAPPORT THERAPEUTICS INC | $36.31 | 0.58% | 185.15% | 58.89% | $4.3M | 0.87% | — | HELD |
| 22 | ASNDUSD | ASCENDIS PHARMA A/S | — | — | — | — | $4.1M | 0.81% | — | HELD |
| 23 | BLTE | BELITE BIO INC | $143.35 | -0.77% | 140.20% | 848.08% | $4.0M | 0.80% | +7,000 | +38.9% |
| 24 | XENE | XENON PHARMACEUTICALS INC | $51.73 | -2.38% | 63.50% | 199.54% | $3.8M | 0.76% | +25,000 | +62.5% |
| 25 | MLYS | MINERALYS THERAPEUTICS INC | $22.85 | -3.52% | 46.96% | 51.28% | $3.7M | 0.75% | — | HELD |
| 26 | ROIV | ROIVANT SCIENCES LTD | $28.41 | -0.61% | 154.50% | 188.40% | $3.6M | 0.72% | — | HELD |
| 27 | PALI | PALISADE BIO INC | $1.74 | -9.84% | 148.57% | -99.92% | $3.5M | 0.70% | — | HELD |
| 28 | BIIB | BIOGEN INC | $195.34 | -0.57% | 46.73% | -40.21% | $3.4M | 0.68% | +18,437 | NEW |
| 29 | PROK | PROKIDNEY CORP | $1.80 | -2.70% | 84.05% | -81.73% | $3.2M | 0.65% | −31,472 | −1.7% |
| 30 | ABBV | ABBVIE INC | $227.23 | 1.02% | 23.60% | 135.68% | $3.2M | 0.63% | — | HELD |
| 31 | UTHR | UNITED THERAPEUTICS CORP DEL | $549.87 | 0.40% | — | — | $3.0M | 0.59% | — | HELD |
| 32 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $67.43 | -2.28% | — | — | $2.8M | 0.56% | +5,000 | +15.0% |
| 33 | PTGX | PROTAGONIST THERAPEUTICS INC | $97.38 | -5.26% | — | — | $2.4M | 0.48% | −20 | −0.1% |
| 34 | SLNO | SOLENO THERAPEUTICS INC | $53.01 | 0.00% | — | — | $2.3M | 0.46% | −515,208 | −88.3% |
| 35 | BTSG | BRIGHTSPRING HEALTH SVCS INC | $59.41 | 3.50% | — | — | $2.3M | 0.46% | +12,200 | +29.3% |
| 36 | TVTX | TRAVERE THERAPEUTICS INC | $46.54 | 1.59% | — | — | $2.1M | 0.42% | — | HELD |
| 37 | EWTX | EDGEWISE THERAPEUTICS INC | $35.59 | -4.41% | — | — | $2.1M | 0.41% | +65,500 | NEW |
| 38 | CELC | CELCUITY INC | $88.24 | -0.05% | — | — | $1.8M | 0.36% | +2,676 | +20.7% |
| 39 | BBIO | BRIDGEBIO PHARMA INC | $66.96 | -0.97% | — | — | $1.5M | 0.30% | — | HELD |
| 40 | KNSA | KINIKSA PHARMACEUTICALS INTL | $48.00 | -0.87% | — | — | $1.4M | 0.28% | — | HELD |
| 41 | CYTK | CYTOKINETICS INC | $70.51 | -1.35% | — | — | $1.1M | 0.22% | +16,300 | NEW |
| 42 | ELVN | ENLIVEN THERAPEUTICS INC | $33.97 | -2.13% | — | — | $819K | 0.16% | +20,900 | NEW |
| 43 | PRAX | PRAXIS PRECISION MEDICINES I | $254.00 | -4.06% | — | — | $805K | 0.16% | — | HELD |
| 44 | TENX | TENAX THERAPEUTICS INC | $10.73 | -3.25% | — | — | $673K | 0.13% | — | HELD |
| 45 | KOD | KODIAK SCIENCES INC | $31.05 | -9.10% | — | — | $649K | 0.13% | — | HELD |
| 46 | NUVL | NUVALENT INC | $89.11 | -2.02% | — | — | $502K | 0.10% | −3,200 | −39.5% |
| 47 | APGE | APOGEE THERAPEUTICS INC | $86.92 | -4.38% | — | — | $495K | 0.10% | +5,886 | NEW |
| 48 | AVTX | AVALO THERAPEUTICS INC | $13.43 | 2.52% | — | — | $433K | 0.09% | −12,600 | −30.3% |
| 49 | PEPG | PEPGEN INC | $1.41 | -4.73% | — | — | $363K | 0.07% | — | HELD |
| 50 | UGL | PROSHARES TR II | $51.18 | -7.30% | — | — | — | — | −542,119 | EXITED |
| 51 | QURE | UNIQURE NV | $26.45 | -5.50% | — | — | — | — | −1,023,539 | EXITED |
| 52 | AZNN | ASTRAZENECA PLC | — | — | — | — | — | — | −190,752 | EXITED |
| 53 | CDTX | CIDARA THERAPEUTICS INC | — | — | — | — | — | — | −70,824 | EXITED |
| 54 | ALNY | ALNYLAM PHARMACEUTICALS INC | $303.05 | -0.19% | — | — | — | — | −17,400 | EXITED |
| 55 | VTYXUSD | VENTYX BIOSCIENCES INC | — | — | — | — | — | — | −695,982 | EXITED |
| 56 | PVLA | PALVELLA THERAPEUTICS INC NE | $109.39 | 0.66% | — | — | — | — | −59,200 | EXITED |
| 57 | RNAGBP | AVIDITY BIOSCIENCES INC | — | — | — | — | — | — | −60,100 | EXITED |
| 58 | OCUL | OCULAR THERAPEUTIX INC | $8.25 | -6.25% | — | — | — | — | −226,261 | EXITED |
| 59 | UPB | UPSTREAM BIO INC | $7.05 | -5.11% | — | — | — | — | −68,653 | EXITED |
| 60 | ANRO | ALTO NEUROSCIENCE INC | $18.26 | -8.84% | — | — | — | — | −29,192 | EXITED |
| 61 | LYRA | LYRA THERAPEUTICS INC | $0.70 | 0.78% | — | — | — | — | −8,756 | EXITED |
Source: SEC EDGAR · accession 0001937964-26-000007. 13F discloses long positions only — shorts, foreign equities, and options are excluded.